Skip to content

Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users.

Carl Alexander Roberts, Andrew Jones, Catharine Montgomery

Neuroscience & Biobehavioral Reviews April 2016 DOI: 10.1016/j.neubiorev.2016.02.003 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis Peer reviewed
Sample size 305
Population 157 ecstasy/MDMA users and 148 polydrug-using controls
Topics MDMA Serotonin
Keywords Meta-analysis Molecular imaging PET Sert Spect
Key findings Ecstasy/MDMA users showed reduced serotonin transporter availability compared with controls across most brain regions studied (overall SMD=0.52), with the largest reduction in the occipital cortex (SMD=1.09) and no differences in the caudate, putamen, or midbrain. The authors conclude that serotonin axons with the longest projections from the raphe nuclei appear most affected by ecstasy/MDMA use.

Abstract

We conducted a meta-analysis on the available data from studies investigating SERTs in ecstasy users and polydrug using controls. From 7 studies we compared data from 157 ecstasy users and 148 controls across 14 brain regions. The main effect suggested ecstasy/MDMA related SERT reductions (SMD=0.52, 95% CIs [0.40, 0.65]; Z=8.36, p<.01, I(2)=89%). A significant effect of subgroups (X(2)=37.41, df=13, p<.01, I(2)=65.3%) suggested differential effects across brain ROIs. Ecstasy users showed significant SERT reductions in 11 out of the 14 regions, including every neocortical and limbic region analysed. Greatest effects were observed in the occipital cortex (SMD=1.09, 95% CIs [0.70, 1.48]). No group effects were observed in subcortical areas of the caudate, putamen and midbrain. Literature on Postsynaptic 5HT2A receptor imaging was synthesised with these results. We conclude that, in line with preclinical data, serotonin axons with the longest projections from the raphe nuclei appear to be most affected by ecstasy/MDMA use.

Comparable studies

Other systematic reviews and meta-analyses on MDMA, most cited first.

Citations in the library

Explore topics